Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

KB Home Insider Trading Activity Spikes

KB Home insider trading activityThomas S Silk, SVP Marketing and Communications at KB Home (NYSE:KBH), just purchased 5,000 shares of common stock, at a price of $6.04 each, for a total transaction worth $30,200. This is not the first transaction made by Mr. Silk concerning KB Home, and his position now amounts to a total of 15,545 shares of common stock. They are all under his direct control and represent a capital investment worth $257,891.


The stock price for KB Home has recently reached a year low, after a steep climb during the first half of the year. The highest price registered has been recorded on May 10, at $24.32 each share of common stock. Since then, the stock price entered a steep decline, registering its lowest point on August 30, at $16.03 per share of common stock.

Besides Mr. Silk, Jeffrey T. Mezger, President and CEO at KB Home, exercised his right to buy 150,000 shares. Jeff Kaminski, Evp& Chief Financial Officer, acquired 15,000 through a grant of restricted common stock, taking his total holding to 36,140 shares. Brian J. Woram, Evp and General Counsel, took his position to a total of 53,747 shares through the same right as Mr. Kamiski. Other important figures benefited by the same right were Thomas F Norton, Svp Human Resources, with 6,000 shares; William R. Hollinger, Svp& Chief Accounting Officer, with 7,000 shares; and Albert Z. Praw, Evp Real State & Business Development, with 12,500 shares.

The stock continues to trade above the $16 mark today, paying $0.025 in quarterly dividends, representing a 0.59% yield. Trading 71.4 times its trailing earnings, the stock carries a premium to the industry average.

Disclosure: Jodor Jalit holds no position at any of the mentioned stock.

Recommended Reading:

Repros Therapeutics: New Drug Development Stimulates Insider Trading

Yum! Brands’ Board of Directors is Eating Up Stock

A Six-Pack of Stocks With Promising Insider Trading Activity

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!